Abstract: A seat assembly includes a first seatback and a second seatback. The first seatback may include a first seatback upper portion and a first seatback lower portion. The second seatback may include a second seatback upper portion and a second seatback lower portion. The seat assembly may further include an intermediate back section including an intermediate upper portion and an intermediate lower portion. The first seatback lower portion and the second seatback lower portion may be arranged on opposite sides of the intermediate lower portion. The seat assembly may also include a carrier frame to which the first seatback upper portion, the second seatback upper portion, and the intermediate upper portion may be connected. At least one of the first seatback upper portion, the second seatback lower portion, and the intermediate upper portion may be adjustably connected to the carrier frame.

Abstract: A seat assembly includes a first seatback and a second seatback. The first seatback may include a first seatback upper portion and a first seatback lower portion. The second seatback may include a second seatback upper portion and a second seatback lower portion. The seat assembly may further include an intermediate back section including an intermediate upper portion and an intermediate lower portion. The first seatback lower portion and the second seatback lower portion may be arranged on opposite sides of the intermediate lower portion. The seat assembly may also include a carrier frame to which the first seatback upper portion, the second seatback upper portion, and the intermediate upper portion may be connected. At least one of the first seatback upper portion, the second seatback lower portion, and the intermediate upper portion may be adjustably connected to the carrier frame.

Abstract: The Invention relates to a medical device (1) for oral procedures, particularly for use in oral intubation and fixation procedures, comprising at least one protective device (2) for teeth, the protective device (2) comprising the a rigid support component (3), and at least one push button (4), arranged at the support component (3), wherein each of the at least one the push button (4) comprises a rigid surface (42) that is facing towards the teeth, when the medical device (1) is applied orally, wherein the support component (3) is configured such that each of the at least one push button (4) is displaceable separately relative to the support component (3) between a first position and a second position.

Abstract: Devices for non-invasive, label-free separation of particles in liquid, including circulating tumors cells in blood, are provided. Embodiments of the disclosure provide for devices employing magnetic fluids and magnets for separation of circulating tumor cells from blood. Methods for separation of particles including circulating tumor cells are also provided.

Abstract: The invention relates to an electric drive system, comprising an n-phase electric machine, n>1, which has at least two single-phase winding strands, a first inverter, the output connection of which is connected to the phase connection of a first of the single-phase winding strands of the electric machine, at least one second inverter, the output connection of which is connected to the phase connection of a second of the single-phase winding strands of the electric machine, and a DC voltage source which has a plurality of series-connected battery modules and the output connections of which are respectively connected to the input connections of the first inverter and to the input connections of the second inverter, so that the first inverter and the second inverter are arranged in parallel.

Abstract: Devices for non-invasive, label-free separation of particles in liquid, including circulating tumors cells in blood, are provided. Embodiments of the disclosure provide for devices employing magnetic fluids and magnets for separation of circulating tumor cells from blood. Methods for separation of particles including circulating tumor cells are also provided.

Abstract: A method and device for influencing the longitudinal velocity of a motor vehicle, in which a setpoint minimum distance and/or a setpoint maximum velocity is presettable by the driver, the driver being able to influence the vehicle velocity via the accelerator pedal and/or brake pedal, and in which the distance from a vehicle traveling ahead is measured by a distance-measuring sensor and, if the setpoint minimum distance is undershot and/or the setpoint maximum velocity is exceeded by the vehicle velocity, the vehicle velocity is limited so that the setpoint minimum distance is not undershot and/or the setpoint maximum velocity is not exceeded. This function is provided, in particular, in connection with an adaptive distance and cruise control system, the driver being able to activate either the adaptive distance and cruise control system or the limiting function.

Abstract: A method and device for influencing the longitudinal velocity of a motor vehicle, in which a setpoint minimum distance and/or a setpoint maximum velocity is presettable by the driver, the driver being able to influence the vehicle velocity via the accelerator pedal and/or brake pedal, and in which the distance from a vehicle traveling ahead is measured by a distance-measuring sensor and, if the setpoint minimum distance is undershot and/or the setpoint maximum velocity is exceeded by the vehicle velocity, the vehicle velocity is limited so that the setpoint minimum distance is not undershot and/or the setpoint maximum velocity is not exceeded. This function is provided, in particular, in connection with an adaptive distance and cruise control system, the driver being able to activate either the adaptive distance and cruise control system or the limiting function.

Abstract: A driver assistance system for motor vehicles, having at least one assistance function that is to be used only under particular preconditions, characterized by an acquisition device for acquiring data concerning the locality in which the vehicle is traveling, and by a blocking device for blocking the assistance function if the acquired data indicate that the preconditions for the use of the assistance function are not met.

Abstract: A method and a device for emitting a warning for a first motor vehicle equipped with an adaptive cruise control are provided, which device includes a unit for detecting if the first vehicle is standing still, as well as a unit for determining the distance and relative speed of a second vehicle, thereby making it possible to detect if a second vehicle located immediately ahead of the first vehicle is rolling backwards while the first vehicle is standing still. If the distance between the first and the second vehicle drops below a minimum distance, a warning is emitted to warn of the impending collision.

Abstract: A cruise control system for motor vehicles is described, having a sensor device for measuring the vehicle's performance characteristics and for measuring the distance to a target object ahead of the vehicle, and a controller which is used to control the vehicle's speed or acceleration as a function of the measured performance characteristics and distance data and has a stop function for automatically braking the vehicle to a standstill as well as at least one standstill state in which the vehicle is held in a stationary position by automatic brake activation, and from which it may only drive off again via an operational command by the driver, the operational command becoming effective only when a confirmation signal is present in addition to the operational command.

Abstract: The use of chemokine receptor CCR5 modulators (e.g., CCR5 antagonists) is disclosed for the treatment or prevention of stress response (e.g., fever) in a subject resulting from surgery, infection or other insult to the subject (e.g., a warm-blooded vertebrate). Methods for treating or preventing disorders involving the activation of pro-inflammatory cytokines by administration of a CCR5 modulator, for inhibiting the endogenous production of pro-inflammatory cytokines by the administration of CCR5 modulators, and for determining the efficacy of CCR5 modulators in correcting abnormal levels of pro-inflammatory cytokines are also disclosed.

Abstract: A cruise control system for motor vehicles is described, having a sensor device for measuring the vehicle's performance characteristics and for measuring the distance to a target object ahead of the vehicle, and a controller which is used to control the vehicle's speed or acceleration as a function of the measured performance characteristics and distance data and has a stop function for automatically braking the vehicle to a standstill as well as at least one standstill state in which the vehicle is held in a stationary position by automatic brake activation, and from which it may only drive off again via an operational command by the driver, the operational command becoming effective only when a confirmation signal is present in addition to the operational command.